Barak Yahalom, DVM

Professional Summary:

Dr. Yahalom is a Research Director at BRM who has 8+ years of intensive international biotech experience in Diabetes, Autoimmune Disorders and Pain includes Acute, Chronic and Neuropathic Pain, Spinal Cord Injury, CNS Disorders and Cancer. Dr. Barak Yahalom received his DVM (2000) and BA degrees (1996) from Hebrew University, Jerusalem, Israel. Prior to BRM, he was a Research Associate in the Anesthesia department at Children's Hospital in Boston, MA, working on several projects including the Design and formulate a unique intratheacal injection technique of local anesthetics to P7 rat pups. He was also Director of Pharmacology at Pharmos Corp. Nes Ziona, Israel.

Publications:

Yahalom B, Athiraman UK, Soriano S, Zurakowski D, Corfas G, Carpino E, Berde CB. Spinal anesthesia in Infant Rats: Development of a Model, Preliminary Observations, and Assessment of Neurologic Outcomes. Anesthesiology, accepted, 2010.

C. Berde, UK. Athiraman, B. Yahalom, D. Zurakowski, G. Corfas, C. Bognet, Anh Ho Ngoc. Tetrodotoxin-Bupivacaine-Epinephrine Combinations for Prolonged Local Anesthesia. Journal of Regional Anesthesia, in preparation.

Anis Y, Leshem O, Reuveni H, Wexler I, Ben Sasson R, Yahalom B, Laster M, Raz I, Ben Sasson S, Shafrir E, Ziv E. Antidiabetic effect of novel modulating peptides of G-protein-coupled kinase in experimental models of diabetes. Diabetologia, 47(7):1232-1244, 2004.